Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain
Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for Knee Pain Related to Osteoarthritis
Sponsor: ZetrOZ, Inc.
Listed as NCT05050448, this PHASE1/PHASE2 trial focuses on Knee Osteoarthritis and remains completed. Sponsored by ZetrOZ, Inc., it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Jun 2025 — Present [monthly]
Completed PHASE1/PHASE2
-
Sep 2024 — Jun 2025 [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jul 2023 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
Status: Recruiting → Completed
-
Oct 2021 — Jul 2023 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Aug 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ZetrOZ, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .